Spotlight On... New molecule targets cancer stem cells; New mouse/human platform at Whitehead; and more...

Liang Fang and fellow researchers in Walter Birchmeier's group at the Max Delbrück Center for Molecular Medicine led a team with colleagues at the Berlin-Buch campus which discovered a molecule that interrupts biochemical signals essential for the survival of a "certain type of cancer stem cell." Targeting cancer item cells has been a growing field in oncology. The work is published ahead of print in the online edition of Cancer Research. Release

> Researchers at the Whitehead Institute created a new mouse-human modeling platform that could be used to study neural crest development as well as cancers such as melanoma and neurofibromatosis. Release

> Scientists at the University of Wisconsin-Madison have been tracking the development of different strains of the Zika virus, part of a widespread effort now underway to better understand Zika and develop a new vaccine to stop it. Release

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.